Detalles de la búsqueda
1.
Targeted gene next-generation sequencing reveals genomic profile in a cohort of 46 Chinese patients with breast cancer.
J Gene Med
; 24(6): e3420, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470535
2.
Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
Breast Cancer Res Treat
; 193(2): 381-392, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35297009
3.
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up.
Breast Cancer Res Treat
; 191(1): 97-105, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648118
4.
Platinum-based chemotherapy in advanced triple-negative breast cancer: A multicenter real-world study in China.
Int J Cancer
; 147(12): 3490-3499, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588429
5.
Carboplatin plus taxanes are non-inferior to epirubicin plus cyclophosphamide followed by taxanes as adjuvant chemotherapy for early triple-negative breast cancer.
Breast Cancer Res Treat
; 182(1): 67-77, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32394350
6.
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients.
Chin J Cancer Res
; 31(5): 759-770, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31814680
7.
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in China.
Int J Cancer
; 143(10): 2499-2504, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978573
8.
The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population.
Int J Cancer
; 143(1): 184-189, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396856
9.
Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial.
Cancer
; 121(19): 3412-21, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26096296
10.
[Efficacy and safety of cisplatin plus capecitabine for patients with metastatic triple negative breast cancer progressing after anthracycline and taxane treatment].
Zhonghua Zhong Liu Za Zhi
; 37(12): 938-41, 2015 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-26887625
11.
[Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes].
Zhonghua Zhong Liu Za Zhi
; 37(10): 788-92, 2015 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-26813602
12.
Efficacy of platinum-based chemotherapy in triple-negative breast cancer patients with metastases confined to the lungs: a single-institute experience.
Anticancer Drugs
; 25(9): 1089-94, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25153786
13.
[Clinicopathological features and prognosis of metastases to the breast from extramammary solid tumors].
Zhonghua Zhong Liu Za Zhi
; 36(6): 453-6, 2014 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-25241789
14.
[Efficacy and safety of trastuzumab plus different chemotherapy regimens in treatment of the patients with HER-2-positive advanced breast cancer].
Zhonghua Zhong Liu Za Zhi
; 36(5): 372-6, 2014 May.
Artículo
en Zh
| MEDLINE | ID: mdl-25030594
15.
[Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs].
Zhonghua Zhong Liu Za Zhi
; 36(10): 788-92, 2014 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-25567313
16.
TNM stage at diagnosis is more predictive of prognosis than pathological complete response in young breast cancer treated with neoadjuvant chemotherapy.
Anticancer Drugs
; 29(2): 176-183, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052637
17.
[Clinical analysis of 34 patients with adrenal metastasis from breast cancer].
Zhonghua Zhong Liu Za Zhi
; 35(11): 855-7, 2013 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-24447485
18.
Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer.
J Huazhong Univ Sci Technolog Med Sci
; 33(2): 262-265, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23592141
19.
[Effects of polysomy 17 on HER-2 gene and protein expression and its clinicopathologic significance in breast cancer].
Zhonghua Yi Xue Za Zhi
; 93(2): 84-8, 2013 Jan 08.
Artículo
en Zh
| MEDLINE | ID: mdl-23648340
20.
Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies.
Biomark Res
; 11(1): 21, 2023 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803645